However, telmisartan also induces anti-fibrotic and anti-obesity effects through PPARδ-dependent pathways37,38 and enacts anti-hepatic fibrosis and anti-dyslipidemic effects through PPARα-dependent pathways4,39. The gene discussed is PPARA; the disease is obesity disorder.